News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Noemi Reguart: First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy in SCLC
Noemi Reguart/X
Apr 13, 2025, 17:50

Noemi Reguart: First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy in SCLC

Noemi Reguart, Medical Oncologist at Hospital Clinic Barcelona, shared a post on X:

“First global Phase 3 trial to show a substantial survival advantage over chemo in 2L SCLC!

Tarlatamab significantly improves OS after progression on platinum-based chemo.

Full topline results.”

More posts featuring SCLC.

 

cancer Lung cancer Noemi Reguart OncoDaily Oncology SCLC small cell lung cancer Tarlatamab
Special Coverage
Blog
May 3, 2025, 14:20
Pierre Blanchard: 10 year results of HYPO RT PC at ESTRO 2025
Blog
May 3, 2025, 14:17
ESMO Gynae25 Conference to Focus on Advances in Gynaecological Cancer Care
Blog
May 3, 2025, 14:11
George E Naoum: Results of DBCG Skagen trial at ESTRO 2025
Blog
May 3, 2025, 13:52
Amil Družić Selected Among Europe’s Rising Talents in Radiation Oncology
Blog
May 3, 2025, 13:46
Mark Bolton: FAST FORWARD Trial results at ESTRO 2025 - Dose-Response and Toxicity
Blog
May 3, 2025, 13:34
Gerry Hanna: ESTRO Lung Focus Group mentor/mentee breakfast meeting at ESTRO 2025
Blog
May 3, 2025, 13:26
Icro Meattini: Honoured to present on behalf of the BRCABCY collaboration at ESTRO 2025
Blog
May 3, 2025, 13:25
Rob Winn: It’s been an incredible experience representing VCU Massey Comprehensive Cancer Center at 2025 AACR Annual Meeting
Blog
May 3, 2025, 13:15
Enrique Soto: Awesome days at the SWOG meeting 2025 in San Francisco
Insight
May 3, 2025, 13:01
ESTRO 2025 Opening Ceremony Kicks Off with Visionary Keynote and Honors in Innovation
Blog
May 3, 2025, 12:57
IARC Launches CHRONOS Center to Monitor Global HPV Vaccination Impact
Opinion
May 3, 2025, 12:34
Preferred Papers from ESTRO 2025: Neoadjuvant Radiotherapy, Lymphocyte Preservation an pCR in Rectal Cancer